| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT01832727 2013-001169-18 Details | 2020-07-13 Interventional | 1/2 | [1 Refs] | 65 | Dexamethasone Multiple Myelom… Neoplasms, Plas… | Enrollment halted during phase 2 to reformulate the investigational product - | ||
| NCT01550510 Details | 2020-07-13 Interventional | 1/2 | 4 | Ascorbic Acid Camptothecin Irinotecan Colorectal Neop… Stage IV Colore… | Closed: low enrollment, many treatment options available for Colorectal Cancer - | |||
| NCT03003728 Details | 2020-07-10 Interventional | 2 | 0 | Elotuzumab Melphalan Multiple Myelom… Neoplasms, Plas… | Withdrawal of study support - | |||
| NCT03628053 Details | 2020-07-09 Interventional | 3 | 0 | Blinatumomab Inotuzumab Ozog… Tisagenlecleuce… Leukemia Leukemia, Lymph… Precursor Cell … Acute Lymphobla… | Novartis is no longer pursuing this study because of planned investigation of novel CAR-T
therapies in this patient population. - | |||
| NCT04271839 Details | 2020-07-07 Interventional | 4 | 0 | Fluticasone Formoterol Fuma… Asthma Persistent Asth… | The trial has been terminated early due to the SARS-CoV-2 pandemic. - | |||
| NCT04236453 2019-002245-37 Details | 2020-07-07 Interventional | 1 | 16 | Cobicistat Cobicistat mixt… Darunavir Emtricitabine Emtricitabine t… Emtricitabine, … Tenofovir Healthy | COVID-19 pandemic impacted the BE assessment of the trial. The clinical team decided to
terminate the trial in order to start a new pivotal BE trial - | |||
| NCT03925155 Details | 2020-07-07 Interventional | 3 | [1 Refs] | 0 | Chlorhexidine Iodine Cesarean Sectio… | The study was withdrawn from the IRB - | ||
| NCT03492710 Details | 2020-07-07 Interventional | 3 | 0 | Antibodies Immunoglobulins Immunoglobulins… Immunologic Def… Primary Immunod… Primary Immune … | A change in sponsor's developmental strategy - | |||
| NCT03010423 Details | 2020-07-07 Interventional | 4 | 8 | Nicorandil Coronary Artery… Coronary Diseas… Myocardial Isch… Non-obstructive… | The study was terminated early, due to the lack of approval of data exportation from the Office
of Human Genetic Resource Administration (OHGRA) China. The study was terminated early and due to the lack of approval of data exportation from the Office of Human Genetic Resource Administration (OHGRA) China, the data could not be extracted. Therefore, no data available for the analyses. | |||
| NCT02169284 Details | 2020-07-07 Interventional | 2 | 50 | Erlotinib Hydro… Carcinoma Urinary Bladder… Bladder Carcino… Recurrent Bladd… | - - | |||
| NCT02708849 Details | 2020-07-02 Interventional | 1 | 3 | Ketamine Lamotrigine Mental Disorder… | - - | |||
| NCT03471559 Details | 2020-07-01 Interventional | 1 | 8 | Cannabidiol Pharmacokinetic… | Two step study, step two was not feasible based on results from phase one. - | |||
| NCT03043274 Details | 2020-06-30 Interventional | 4 | 23 | Cangrelor Infarction Myocardial Infa… ST Elevation My… STEMI - ST Elev… | - The study was terminated because of slow recruitment. | |||
| NCT02561897 Details | 2020-06-30 Interventional | 4 | 5 | Edoxaban Warfarin Atrial Fibrilla… | Did not meet enrolment target for phase 1 - | |||
| NCT03053050 2016-004374-18 Details | 2020-06-29 Interventional | 3 | [7 Refs] | 808 | Selonsertib Fatty Liver Non-alcoholic F… Nonalcoholic St… | This study was terminated early due to lack of efficacy based on the results of the Week 48
analysis as prespecified in the clinical study protocol. Based on the results of the Week 48 analysis, the study was terminated early for lack of efficacy as prespecified in the clinical study protocol. | ||
| NCT02138838 2013-004958-18 Details | 2020-06-29 Interventional | 3 | 55 | Cinacalcet Hyperparathyroi… Hyperparathyroi… Kidney Diseases Neoplasm Metast… Renal Insuffici… Chronic Kidney … | Amgen decided to terminate the study early to be able to meet US regulatory timelines fo
filing. Subjects in treatment were rolled over to the 20140159 study. - | |||
| NCT04329403 Details | 2020-06-26 Interventional | 3 | 0 | Adapalene Acne Vulgaris | Market reasons - | |||
| NCT04231682 Details | 2020-06-26 Interventional | 2 | 0 | Denosumab Osteoporosis | Grant support was withdrawn from Amgen Pharmaceuticals - | |||
| NCT03891979 Details | 2020-06-26 Interventional | 4 | 0 | Ciprofloxacin Metronidazole Pembrolizumab Adenocarcinoma Pancreatic Canc… | Suspended due to Primary Investigator's decision - | |||
| NCT03827473 Details | 2020-06-25 Interventional | 2 | 1 | Abiraterone Ace… Androgen Antago… Androgens Ascorbic Acid Cortisone Docetaxel Estrogens, Conj… Hormones Methyltestoster… Prednisone Hypersensitivit… Prostatic Neopl… Castration-Sens… Metastatic Pros… Stage IV Prosta… Stage IVA Prost… Stage IVB Prost… | The trial was closed because the changing standard of care landscape, making this trial not
impactful anymore. - |